NYSE · CHD
Consumer Defensive · Household & Personal Products
$97.73
Up+$0.38 (+0.39%)
Updated Oct 9, 2026, 11:18 PM
SID Score
6.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CHD
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
CHD closed at $97.73 after 21 trading sessions, up 4.03% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $96.85 | $98.28 | $96.2201 | $97.73 | 1.69M |
| Oct 7, 2026 | $96.73 | $97.55 | $96.52 | $96.75 | 1.82M |
| Oct 6, 2026 | $96.13 | $97.42 | $95.9813 | $96.54 | 1.41M |
| Oct 5, 2026 | $94.64 | $95.96 | $94.24 | $95.66 | 2.01M |
| Oct 2, 2026 | $94.41 | $94.98 | $93.925 | $94.31 | 2.18M |
| Oct 1, 2026 | $93.80 | $94.43 | $93.33 | $94.11 | 2.51M |
| Sep 30, 2026 | $95.44 | $95.84 | $94.22 | $94.22 | 2.38M |
| Sep 29, 2026 | $95.05 | $95.74 | $94.54 | $94.95 | 2.25M |
| Sep 28, 2026 | $95.80 | $95.97 | $94.80 | $95.62 | 1.53M |
| Sep 25, 2026 | $95.31 | $96.78 | $94.90 | $96.38 | 997.59K |
| Sep 24, 2026 | $96.37 | $97.04 | $95.27 | $95.33 | 1.25M |
| Sep 23, 2026 | $96.12 | $96.86 | $95.69 | $96.02 | 1.15M |
| Sep 22, 2026 | $96.29 | $96.66 | $95.81 | $96.12 | 1.65M |
| Sep 21, 2026 | $94.55 | $95.735 | $94.355 | $95.49 | 1.93M |
| Sep 18, 2026 | $94.01 | $95.39 | $94.01 | $94.75 | 2.27M |
| Sep 17, 2026 | $95.98 | $96.28 | $94.965 | $95.05 | 1.62M |
| Sep 16, 2026 | $94.76 | $95.72 | $94.25 | $95.51 | 1.84M |
| Sep 15, 2026 | $93.99 | $94.94 | $93.38 | $94.51 | 2.45M |
| Sep 14, 2026 | $95.26 | $95.69 | $94.46 | $94.58 | 1.9M |
| Sep 11, 2026 | $94.55 | $94.555 | $93.035 | $94.15 | 1.95M |
| Sep 10, 2026 | $95.23 | $95.29 | $93.61 | $93.94 | 2.11M |
The latest Smart Investors Daily articles mentioning CHD.
Company
Market Activity
Research & News
CHD research
Company profile and research snapshot.
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2026 | Wells Fargo | Overweight | — |
| Aug 3, 2026 | UBS | Neutral | — |
| Aug 3, 2026 | RBC Capital | Outperform | — |
| Aug 3, 2026 | TD Cowen | Hold | — |
| Aug 3, 2026 | Citigroup | Neutral | — |
No generated briefing is available yet.
Yahoo · Sep 30, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Yahoo · Sep 28, 2026
Procter & Gamble's China Baby Care regains as premium innovation drives double-digit organic sales growth, share gains and a return to the No. 1 position.
Yahoo · Sep 27, 2026
Colgate-Palmolive has sent dividend checks without interruption since Grover Cleveland's second term, but a 130-year streak and a shrinking North American business now sit in uncomfortable tension with a premium valuation that leaves almost no room for error.
Yahoo · Sep 24, 2026
Bond yields are surging, oil is above $100, and rate expectations keep shifting, so the hunt is on for businesses that can still defend pricing and cash flows when money gets more expensive. This backdrop can reward investors who focus on resilience rather than excitement. In this article you will see three global consumer staples and utilities stocks exposed to these shocks and how the news could matter for their long term appeal. The three stocks below are a small sample of what investors...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CHD.
